Prosecution Insights
Last updated: May 29, 2026

Examiner: ROSSI, VY BUI

Tech Center 1600 • Art Units: 1671 1685

This examiner grants 32% of resolved cases

Performance Statistics

31.7%
Allow Rate
-28.3% vs TC avg
62
Total Applications
+44.0%
Interview Lift
1558
Avg Prosecution Days
Based on 41 resolved cases, 2023–2026

Rejection Statute Breakdown

6.8%
§101 Eligibility
6.1%
§102 Novelty
41.2%
§103 Obviousness
4.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17270072 SYSTEMS AND METHODS FOR PROVIDING CONTAINER BASED MEDICATION DOSE GUIDANCE TO TREAT DIABETES Final Rejection Novo Nordisk A/S
16903231 CANCER SCREENING USING METHYLATION OF CPG ISLANDS Final Rejection The Chinese University of Hong Kong
17274155 METHOD TO DETERMINE IF A CIRCULATING FETAL CELL ISOLATED FROM A PREGNANT MOTHER IS FROM EITHER THE CURRENT OR A HISTORICAL PREGNANCY Non-Final OA Illumina Cambridge Limited
17275653 METHOD AND APPARATUS FOR DETECTING COPY NUMBER VARIATIONS IN A GENOME Non-Final OA The Jackson Laboratory
17313707 PATHOGEN TESTING Non-Final OA BATTELLE MEMORIAL INSTITUTE
17296157 VECTOR-BASED HAPLOTYPE IDENTIFICATION Final Rejection KWS SAAT SE & Co. KGaA
18096449 Method of Detecting Viral Infection Using Primary and Secondary Hematology Parameters Non-Final OA Beckman Coulter, Inc.
18659964 SYSTEMS AND METHODS FOR GENERATIVE DESIGN OF CUSTOM BIOLOGICS Final Rejection Pythia Labs, Inc.
18544214 METHODS AND SYSTEMS FOR THERAPY MONITORING AND TRIAL DESIGN Final Rejection Scipher Medicine Corporation
17346060 MONITORING MUTATIONS USING PRIOR KNOWLEDGE OF VARIANTS Non-Final OA Roche Sequencing Solutions, Inc.
17930460 COMPOSITIONS AND METHODS FOR DIAGNOSING COLORECTAL CANCER Non-Final OA GeneGenieDx Corporation
17079515 CENTRALIZED MEDICAL TEST HUB Non-Final OA Assaya LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month